Search

• Public Health Action (PHA) is a peer-reviewed scholarly journal that actively encourages, communicates and reports new knowledge, dialogue and controversy in health systems and services for poor and vulnerable people.

  We encourage young researchers to submit…

• Format for article types

  Original Articles: text up to 2500 words, a structured summary of 200 words, 5 moderate-sized tables/figures and 35 references.

  Minireview: text up to 2,000 words, a structured or unstructured summary of 250 words, 5 moderate-sized…

• Publication Fees

  As an Open Access, online journal, all articles accepted for publication (Correspondence excepted) incur a publication fee of €2300 to cover the cost of reviewing, editing, typesetting and publishing each article.

  These Open Access…

• We use single-anonymous peer review (i.e., the reviewers know the identify of the authors of an article, but the authors do not know the identity of the reviewers).  This allows reviewers to give feedback without fear of any…

• Editor-in-Chief: Ghulam Nabi Kazi (MBBS, MPH, MPA) Editorial Office: Director of Publications: Hugh Blackbourn (PhD), Editorial Coordinator: Rasha Jerandi
• Associate Editors:

  Shahzad Ali Khan

  Health Services Academy, Islamabad, Pakistan

  Nadia Aït-Khaled

  Union Consultant, Algiers, Algeria

  Khalif Bile Mohamud

  …

• We have expanded the scope of PHA to provide broad coverage of relevant areas of the Sustainable Development Goals (SDGs) set by the United Nations.

  The Editors will consider any manuscript reporting original research on progress to achieving these SDGs.

  Suitable…

Public Health Action aims to disseminate the latest operational research on health systems, public health and disease control.

We have recently expanded the scope of PHA to provide coverage of relevant areas of the UN's Sustainable…

The Union has managed 495 Bloomberg tobacco control grants in 45 countries.

Padma Shri Dr Gulshan Rai Khatri, a legendary figure on the front lines of India's fight against TB, sadly died earlier this month, aged 76.

• Read all issues of IJTLD OPEN for FREE. Click the title to access the open access PDF.
• EDITORIAL

  Rethinking latent TB? Think again R.E. Chaisson, P.C. Hopewell 

  ORIGINAL ARTICLES

  Outcomes of people with TB reported to the WHO Global Clinical Platform of COVID-19 M. Bastard, et al.

  Yield of TB screening in prisons in Tajikistan S. Moe, et…

• EDITORIAL

  Update on IJTLD OPEN: the future is open H.D. Blackbourn, G.B. Migliori 

  ORIGINAL ARTICLES

    A 10-year review of isoniazid-resistant TB management in Uzbekistan 2009-2020 M.L. Rekart, et al. Severe outcomes among adults with TB during COVID…

• EDITORIAL

  Embracing novel thinking to safeguard against airborne pathogens in indoor spaces H. van der Westhuizen, et al.

  ORIGINAL ARTICLES

  Cost and cost-effectiveness of BPaL regimen used in drug-resistant TB treatment in the Philippines D. Evans, et al.  …

• EDITORIAL

  Comprehensive care for people affected by TB: addressing TB-associated disabilities M. Calvi, et al. 

  ORIGINAL ARTICLES

  Disability, comorbidities and risk determinants at end of TB treatment in Kenya, Uganda, Zambia and Zimbabwe S.A. Adakun, et al.…

• EDITORIAL

  A publicly accessible global data repository – the WHO TB-IPD platform R. L. Goodall, et al. 

  ORIGINAL ARTICLES

  A pilot cross-sectional study of non-communicable diseases in TB household contacts Y. Hamada, et al.  

  Characteristics of and…

• EDITORIAL

  Guidelines for the diagnosis and management of post-TB lung disease: a call to action D.R. Silva, S. Inwentarz 

  VIEWPOINT

  Operational research as a mechanism to improve treatment outcomes for drug-resistant TB in the WHO European Region G.B. Migliori…

• EDITORIAL

  Applying ‘timeliness’ to the screening and prevention of TB in household contacts of pulmonary TB patients A. D. Harries, et al.

  ORIGINAL ARTICLES

  A social enterprise model for TB detection and treatment through the private sector in Pakistan S. M. A.…

• EDITORIALS

  Launch of IJTLD OPEN: a new home for open access papers on respiratory disease H. D. Blackbourn & G. B. Migliori Global reporting on TB in children and adolescents: how far have we come and what remains to be done? S. Verkuijl, et al. More is needed to…

Cristiane Vianna is The Union’s Technical Advisor for tobacco control in Brazil.

• Peer review process

  We use single-anonymous peer review (i.e., the reviewers know the identify of the authors of an article, but the authors do not know the identity of the reviewers).  This allows reviewers to give feedback without…

• Editor-in-Chief:

  Professor Giovanni Battista Migliori (Care and Research Institute, Tradate, Italy)

  Deputy Editors:

  Isabella Annesi-Maesano (University Hospital of Montpellier, Montpellier, France), Catherine Ong (Dept of Medicine…

• Associate Editors:

  Onno W Akkerman (University Medical Center Groningen, Pulmonary Medicine, The Netherlands)

  Jan W Alffenaar (Sydney School of Pharmacy, The University of Sydney, Australia)

  Gustavo Amorim (Vanderbilt University Medical…

• ISSN 1027-3719 (Print) e-ISSN 1815-7920 (Online)

  The IJTLD is the reference for clinical research and epidemiological studies on TB. It is also the leading peer-reviewed journal dedicated to lung health worldwide, including articles on TB-HIV and non tuberculosis…

• The International Journal of Tuberculosis and Lung Disease (IJTLD) is published by The Union. The IJTLD's main aim is the continuing education academics, clinicians and other health personnel, and the dissemination of the most up-to-date information in the fields…

• The Journal is indexed and/or abstracted in the following media: Medline, PubMed, EMBASE, Web of Science, SciSearch®, Medical Documentation Service®, ISI Alerting Services, Current Contents®/Clinical Medicine, the Science Citation Index®, the SIIC databases, CLOCKSS and…

The IJTLD is the leading peer-reviewed journal dedicated to lung health worldwide.

We welcome submissions on basic, translational, clinical, epidemiological and programmatic research relevant to the Union’s mission to find health…

The Abstract Book of the annual Union World Conference, published every year as a supplement to the International Journal of Tuberculosis and Lung Disease (IJTLD), has been distributed in electronic format since 2004. It is no longer distributed either in print or on CD. The…

• Chinese ISSN 1006-6942

  Dates: 1997-2011 Number of issues: 3 issues yearly for 14 years, i.e., 42 Number of copies distributed: 4000 No of articles published: 280

   

  French ISSN 1815-8439

  Start date: 1997 Number of issues to date: IJTLD Volumes 1-21…

Dates: 1997-2011 Number of issues: 3 issues yearly for 14 years, i.e., 42 Number of copies distributed: 4000 No of articles published: 280

Start date: 1997 Number of issues to date: IJTLD Volumes 1-21 (2017). Online only, updated annually No of articles translated to date: 597 Certains articles du IJTLD, intéressant tout particulièrement la pratique de la lutte contre la tuberculose sur le terrain, sont…

Start date: 2003 Number of issues to date: 4 Number of copies distributed: 1500; now online only No of articles published to date: 54

Start date: 2001 Published online only No of articles published to date: 52

• All articles submitted to the IJTLD will be checked using the iTHENTICATE plagiarism detection software.

  A specific process is followed to manage a case of plagiarism.  The IJTLD follows the guidelines contained in the Committee on Publication Ethics (COPE)…

• Original articles Pre-submission queries are not required for Original articles. Authors are requested to submit their articles directly via Manuscript Central. If an article is deemed unsuitable for publication the authors are assured of a rapid response. State of the Art…

• Open Access (OA)

  Because of the Coalition S mandate prohibiting OA articles in hybrid journals, OA is no longer an option for the IJTLD. Instead authors are directed to IJTLD Open, which is fully compliant with the OA policy.

  Colour Figures

  As the IJTLD transitions…

text

All work must have been approved by all co-authors prior to submission. Authorship credit should be based on the following criteria: 1) substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; 2) drafting the article or…

• The IJTLD is the reference for clinical research and epidemiological studies on lung health worldwide, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution.

  IJTLD OPEN…

• Our Editor-in-Chief works alongside an active Editorial Board to minimise the time taken for key peer review stages so the process is as quick as possible. Data for 2023 is:

• Please note, although authors for IJTLD and IJTLD Open submit their manuscripts via the same portal, this is to ensure we apply the same rigour to peer review for open access and subscription content. Also IJTLD Open has a much broader scope of coverage and content types…

To hold governments accountable for global commitments and to find solutions to TB and lung disease, it is essential to place people with lived experiences central in the conversation.

Indonesia has issued a decree containing a provision for increasing tobacco taxes to fund universal health care, health systems and health programmes.